Danillo Alencar Roseno, Tatiana da Silva Sempé, Thanyse de Oliveira Schmalfuss, C. Giugliani, Tatiane da Silva Dal Pizzol
{"title":"用于治疗哺乳期消化不良和便秘的药物的包装插页说明","authors":"Danillo Alencar Roseno, Tatiana da Silva Sempé, Thanyse de Oliveira Schmalfuss, C. Giugliani, Tatiane da Silva Dal Pizzol","doi":"10.5712/rbmfc19(46)3758","DOIUrl":null,"url":null,"abstract":"Introduction: The safety and effectiveness of medication use during lactation are concerns for mothers and healthcare professionals. This research analyzes the instructions on the leaflets of medications commonly prescribed for dyspepsia and constipation, which aims to provide essential information to guide therapeutic decisions during this crucial period of motherhood. Objectives: To analyze the information in package inserts about contraindications of drugs for dyspepsia and constipation during breastfeeding, verifying whether these are consistent with scientific evidence. Methods: Drugs for dyspepsia and constipation were selected according to the Anatomical Therapeutic Chemical (ATC) classification and active registry in Brazil. The presence of contraindications for the use of medications in the health professional's and patient's package inserts was compared with the information in the technical manual of the Ministry of Health, Medications and Mothers' Milk, LactMed, UptoDate, Micromedex, Documento Científico da Sociedade Brasileira de Pediatria and Reprotox. Results: No information about use during breastfeeding was found in 20.0 and 24.3% of leaflets for dyspepsia and constipation, respectively. The agreement between the leaflets of medications for dyspepsia and the sources consulted was low (27.2% of the leaflets contraindicated the medication during lactation, while in the sources the percentage of contraindication varied from 0 to 8.3%). In relation to medicines for constipation, 26.3% of the leaflets contraindicated them, while in the sources the percentage ranged from 0 to 4.8%. Conclusions: The study pointed out that at least two out of every ten package inserts for dyspepsia and constipation do not provide adequate information on the use of these drugs in infants, and also shows low concordance between the text of the package inserts and the reference sources regarding compatibility of the drug with breastfeeding.","PeriodicalId":510439,"journal":{"name":"Revista Brasileira de Medicina de Família e Comunidade","volume":"112 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Instructions in package inserts intended for the use of medicines for dyspepsia and constipation during lactation\",\"authors\":\"Danillo Alencar Roseno, Tatiana da Silva Sempé, Thanyse de Oliveira Schmalfuss, C. Giugliani, Tatiane da Silva Dal Pizzol\",\"doi\":\"10.5712/rbmfc19(46)3758\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: The safety and effectiveness of medication use during lactation are concerns for mothers and healthcare professionals. This research analyzes the instructions on the leaflets of medications commonly prescribed for dyspepsia and constipation, which aims to provide essential information to guide therapeutic decisions during this crucial period of motherhood. Objectives: To analyze the information in package inserts about contraindications of drugs for dyspepsia and constipation during breastfeeding, verifying whether these are consistent with scientific evidence. Methods: Drugs for dyspepsia and constipation were selected according to the Anatomical Therapeutic Chemical (ATC) classification and active registry in Brazil. The presence of contraindications for the use of medications in the health professional's and patient's package inserts was compared with the information in the technical manual of the Ministry of Health, Medications and Mothers' Milk, LactMed, UptoDate, Micromedex, Documento Científico da Sociedade Brasileira de Pediatria and Reprotox. Results: No information about use during breastfeeding was found in 20.0 and 24.3% of leaflets for dyspepsia and constipation, respectively. The agreement between the leaflets of medications for dyspepsia and the sources consulted was low (27.2% of the leaflets contraindicated the medication during lactation, while in the sources the percentage of contraindication varied from 0 to 8.3%). In relation to medicines for constipation, 26.3% of the leaflets contraindicated them, while in the sources the percentage ranged from 0 to 4.8%. Conclusions: The study pointed out that at least two out of every ten package inserts for dyspepsia and constipation do not provide adequate information on the use of these drugs in infants, and also shows low concordance between the text of the package inserts and the reference sources regarding compatibility of the drug with breastfeeding.\",\"PeriodicalId\":510439,\"journal\":{\"name\":\"Revista Brasileira de Medicina de Família e Comunidade\",\"volume\":\"112 6\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Brasileira de Medicina de Família e Comunidade\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5712/rbmfc19(46)3758\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Brasileira de Medicina de Família e Comunidade","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5712/rbmfc19(46)3758","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
导言:哺乳期用药的安全性和有效性是母亲和医护人员关心的问题。本研究分析了治疗消化不良和便秘的常用处方药宣传页上的说明,旨在提供重要信息,指导母亲在这一关键时期的治疗决策。研究目的分析说明书中有关哺乳期消化不良和便秘的药物禁忌信息,验证这些信息是否与科学证据相符。方法:根据解剖学治疗化学(ATC)分类和巴西的有效登记情况,选择了治疗消化不良和便秘的药物。将卫生部技术手册、《药物与母乳》、《LactMed》、《UptoDate》、《Micromedex》、《Documento Científico da Sociedade Brasileira de Pediatria》和《Reprotox》中的信息与卫生专业人员和患者包装说明书中的用药禁忌进行比较。结果:分别有 20.0% 和 24.3% 的消化不良和便秘药物宣传页中没有关于哺乳期用药的信息。治疗消化不良药物的宣传单与所查阅的资料之间的一致性较低(27.2%的宣传单说明哺乳期禁用药物,而资料中禁用药物的比例从 0 到 8.3% 不等)。至于治疗便秘的药物,26.3%的宣传单上有禁忌,而资料来源中的禁忌比例从 0 到 4.8%不等。结论研究指出,在每十种治疗消化不良和便秘的包装说明书中,至少有两种没有提供有关婴儿使用这些药物的充分信息,同时还显示,在药物与母乳喂养的兼容性方面,包装说明书的文字与参考资料之间的一致性很低。
Instructions in package inserts intended for the use of medicines for dyspepsia and constipation during lactation
Introduction: The safety and effectiveness of medication use during lactation are concerns for mothers and healthcare professionals. This research analyzes the instructions on the leaflets of medications commonly prescribed for dyspepsia and constipation, which aims to provide essential information to guide therapeutic decisions during this crucial period of motherhood. Objectives: To analyze the information in package inserts about contraindications of drugs for dyspepsia and constipation during breastfeeding, verifying whether these are consistent with scientific evidence. Methods: Drugs for dyspepsia and constipation were selected according to the Anatomical Therapeutic Chemical (ATC) classification and active registry in Brazil. The presence of contraindications for the use of medications in the health professional's and patient's package inserts was compared with the information in the technical manual of the Ministry of Health, Medications and Mothers' Milk, LactMed, UptoDate, Micromedex, Documento Científico da Sociedade Brasileira de Pediatria and Reprotox. Results: No information about use during breastfeeding was found in 20.0 and 24.3% of leaflets for dyspepsia and constipation, respectively. The agreement between the leaflets of medications for dyspepsia and the sources consulted was low (27.2% of the leaflets contraindicated the medication during lactation, while in the sources the percentage of contraindication varied from 0 to 8.3%). In relation to medicines for constipation, 26.3% of the leaflets contraindicated them, while in the sources the percentage ranged from 0 to 4.8%. Conclusions: The study pointed out that at least two out of every ten package inserts for dyspepsia and constipation do not provide adequate information on the use of these drugs in infants, and also shows low concordance between the text of the package inserts and the reference sources regarding compatibility of the drug with breastfeeding.